Publication: Human monoclonal scfvs that neutralize fribrinogenolytic activity of kaouthiagin, a zinc-metalloproteinase in cobra (Naja kaouthia) venom
4
Issued Date
2018-12-01
Resource Type
ISSN
20726651
Other identifier(s)
2-s2.0-85058336274
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Toxins. Vol.10, No.12 (2018)
Suggested Citation
Jirawat Khanongnoi, Siratcha Phanthong, Onrapak Reamtong, Anchalee Tungtronchitr, Wanpen Chaicumpa, Nitat Sookrung Human monoclonal scfvs that neutralize fribrinogenolytic activity of kaouthiagin, a zinc-metalloproteinase in cobra (Naja kaouthia) venom. Toxins. Vol.10, No.12 (2018). doi:10.3390/toxins10120509 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/45860
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Human monoclonal scfvs that neutralize fribrinogenolytic activity of kaouthiagin, a zinc-metalloproteinase in cobra (Naja kaouthia) venom
Other Contributor(s)
Abstract
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. Snake venom-metalloproteinases (SVMPs) are the primary factors that disturb hemostasis and cause hemorrhage in the venomous snake bitten subjects. Kaouthiagin is a unique SVMP that binds and cleaves von Willebrand factor (vWF) at a specific peptide bond leading to inhibition of platelet aggregation, which enhances the hemorrhage. Kaouthiagin is a low abundant venom component of Thai cobra (Naja kaouthia); thus, most horse-derived antivenins used for cobra bite treatment do not contain adequate anti-kaouthiagin. This study aimed to produce human single-chain antibody variable fragments (HuscFvs) that bind to and interfere with kaouthiagin activity for further clinical use. Kaouthiagin was purified from N. kaouthia-holovenom by a single-step gel-filtration chromatography. The purified venom component was used in phage-biopanning to select the kaouthiagin-bound HuscFv-displayed-phage clones from a HuscFv-phage display library. The selected phages were used to infect Escherichia coli bacteria. Soluble HuscFvs expressed by three phage-transformed-E. coli clones interfered with cobra kaouthiagin binding to human vWF. Computerized simulation indicated that HuscFv of two phage-transformed E. coli clones formed contact interface with kaouthiagin residues at or near catalytic site and effectively inhibited fibrinogenolytic activity of the kaouthiagin. The HuscFvs have therapeutic potential as an adjunct of antivenins in treatment of bleeding caused by venomous snakebites.